Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 55 | Issue 2 | 2021 | pp. 581–589Open access
Designing of Thiazolidin-4-one Pharmacophore using QSAR Studies for Anti-HIV Activity
- 1*,
- 1,
- 1,
- 1
- 1 Department of Pharmaceutical Chemistry, All India Shri Shivaji Memorial Society’s College of Pharmacy, Kennedy Road, Near R.T.O., Pune, Maharashtra, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Trupti Sameer Chitre
Department of Pharmaceutical Chemistry, All India Shri Shivaji Memorial Society’s College of Pharmacy, Kennedy Road, Near R.T.O., Pune, Maharashtra, INDIA.
Email: chitretrupti@rediffmail.com
Copyright: © 2021 Manuscript Technomedia. This is an open access article.
- Published:
- May 15, 2021
- Received:
- Oct 9, 2019
- Accepted:
- Feb 3, 2021
How to cite
Chitre, T. S., Patil, S. M., Sujalegaonkar, A. G., & Asgaonkar, K. D. (2021). Designing of Thiazolidin-4-one Pharmacophore using QSAR Studies for Anti-HIV Activity. Indian Journal of Pharmaceutical Education and Research, 55(2), 581–589. https://doi.org/10.5530/ijper.55.2.97
Abstract
Background and Aim: In an effort of drug development in the area of HIV, present work deals with development of 2D and 3D QSAR of thiazolidinone derivatives against HIV-RT activity as a powerful method for elucidation the relationships between structure and activity. Materials and Methods: 2D QSAR and 3D QSAR were performed using MLR and SA kNN method respectively. Models which had higher predictability were generated as indicated from their statistical parameters. Results and Discussion: Best models generated showed correlation coefficient r2= 0.9256 and q2 =0.8623 for 2D QSAR and q2 =0.8444 for 3D QSAR. The models indicated the requirement of electro topological, electrostatic and steric descriptors which would significantly contribute to HIV-RT inhibitory activity. Further a few compounds were designed using the outcome of QSAR studies.
Keywords
Subject
Article metadata
| Title | Designing of Thiazolidin-4-one Pharmacophore using QSAR Studies for Anti-HIV Activity |
|---|---|
| Authors | Trupti Sameer Chitre; Shital Manoj Patil; Anagha Govindrao Sujalegaonkar; Kalyani Dhirendra Asgaonkar |
| Affiliations | Department of Pharmaceutical Chemistry, All India Shri Shivaji Memorial Society’s College of Pharmacy, Kennedy Road, Near R.T.O., Pune, Maharashtra, INDIA. |
| Corresponding author | chitretrupti@rediffmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 55, Issue 2 (2021) |
Also in this issue
- Artificial Intelligence in Pharmacypp. 304–318
- Possible Insights into the Use of Silver Nanoparticles in Targeting SARS-CoV-2 (COVID-19)pp. 319–329
- An Overview of Dual Targeting Nanostructured Lipid Carriers for the Treatment of Ovarian Cancerpp. 330–335
- Overview of FBO Licensing in the India and New Dietary Ingredient Notification in the USpp. 336–345
- Targeted Drug Delivery System: Advantages, Carriers and Strategiespp. 346–353
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026